Form 4: Fulgent Genetics CEO Sells Shares for Tax Obligations

Fulgent Genetics CEO Ming Hsieh disposed of 2,116 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Ming Hsieh, Chief Executive Officer, Director, and 10% Owner of Fulgent Genetics, Inc. (FLGT), reported a transaction.
• On November 23, 2025, 2,116 shares of common stock were disposed of.
• The disposition was made to satisfy tax withholding obligations that arose upon the vesting of restricted stock units (RSUs) granted to Mr. Hsieh on February 23, 2023.
• The shares were valued at $30 per share for the purpose of this transaction.
• Following this transaction, Mr. Hsieh directly beneficially owns 802,165 shares.
• Indirect beneficial ownership includes 7,895,115 shares held by the Dynasty Trust, 220,816 shares held by The Ming Hsieh Trust, and 2,000 shares held in Uniform Transfer to Minor Accounts.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related disposition of shares upon RSU vesting, which is a neutral event for the company's operational performance or strategic direction. It does not indicate a change in management's confidence or company fundamentals.

Negatives

• Ming Hsieh, a key insider, disposed of 2,116 shares of common stock, reducing his direct beneficial ownership.

Future Outlook

NA

Industry Context

This is a routine insider transaction related to compensation and tax obligations, common across all industries for executives receiving equity-based awards. It does not reflect specific industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minor dilution from the shares being withheld, but this is a standard and expected part of equity compensation plans. No material impact on company valuation or strategy.

Key Dates

Keywords

Fulgent Genetics, FLGT, Ming Hsieh, Insider Transaction, Form 4, Stock Disposition, Tax Withholding, Restricted Stock Units, CEO, Director, 10% Owner